美国放射学会适宜性标准®肺癌筛查:2022年更新
本文为美国放射学会(ACR)2022年更新的肺癌筛查适宜性标准。文章回顾了美国预防服务工作组(USPSTF)2015年与2021年肺癌筛查标准的变化(年龄上限从77岁提高至80岁,吸烟包年数从30包年降至20包年),并指出不符合更新标准但有额外危险因素者的筛查仍存争议。指南采用GRADE及RAND/UCLA适宜性方法,基于同行评议文献系统分析制定推荐。
要点
- USPSTF 2021年标准将筛查年龄上限提高至80岁,吸烟包年数降至20包年。
- 不符合更新USPSTF标准但有额外肺癌危险因素者的筛查仍存争议。
- ACR适宜性标准采用GRADE及RAND/UCLA方法,基于同行评议文献系统分析制定。
核心结论
- annual low-dose CT screening for lung cancer saves lives,continued implementation can save many more。
- USPSTF 2021年新标准将筛查年龄上限降至80岁、吸烟包年数降至20包年。
- 不符合更新USPSTF标准但有额外肺癌危险因素者的筛查仍存争议。
研究设计与样本
- 美国放射学会(ACR)适宜性标准为基于证据的指南,由多学科专家小组每年审查。
- 指南制定与修订过程支持对同行评议期刊医学文献进行系统分析。
- 采用GRADE等既定方法学原则评估证据。
- 采用RAND/UCLA适宜性方法用户手册确定特定临床场景下影像与治疗程序的适宜性。
- 同行评议文献缺乏或模棱两可时,专家可作为主要证据来源形成推荐。
诊断标准与关键数值
- 2015年CMS覆盖的年度肺癌筛查标准:年龄55至77岁、吸烟史30包年、目前吸烟或既往15年内吸烟。
- 2021年USPSTF新筛查指南:年龄上限提高至80岁,吸烟包年数降至20包年。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 不符合更新USPSTF标准但有额外肺癌危险因素者的筛查仍存争议。
- 同行评议文献缺乏或模棱两可时,专家可作为主要证据来源形成推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Lung cancer remains the leading cause of cancer-related mortality for men and women in the United States. Screening for lung cancer with annual low-dose CT is saving lives, and the continued implementation of lung screening can save many more. In 2015, the CMS began covering annual lung screening for those who qualified based on the original United States Preventive Services Task Force (USPSTF) lung screening criteria, which included patients 55 to 77 year of age with a 30 pack-year history of smoking, who were either currently using tobacco or who had smoked within the previous 15 years. In 2021, the USPSTF issued new screening guidelines, decreasing the age of eligibility to 80 years of age and pack-years to 20. Lung screening remains controversial for those who do not meet the updated USPSTF criteria, but who have additional risk factors for the development of lung cancer. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Sandler KL, Henry TS, Amini A, et al. ACR Appropriateness Criteria® Lung Cancer Screening: 2022 Update. J Am Coll Radiol. 2023. PMID: 37236754. doi:10.1016/j.jacr.2023.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。